In our study, we found that CSF levels of t-tau and p-tau are higher in AD than in CTL and hence t-tau and p-tau are much lower in iNPH than in AD, allowing to differentiate iNPH from AD. The gene discussed is MAPT; the disease is Alzheimer disease.